Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-068455

CBO & COO gave up 11,185 shares (to pay taxes)

  • CBO & COO acquired 26,667 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Klein Lawrence Otto CBO & COO 2021-12-03 Option exercise +26,667 33,510 D
Klein Lawrence Otto CBO & COO 2021-12-06 Shares withheld for taxes −11,185 $69.17 $773,666 22,325 D
Derivatives
Klein Lawrence Otto CBO & COO 2021-12-03 Option exercise · Restricted Stock Units +26,667 13,333 D
Loading xslF345X03/doc4.xml…